MS vs PMCB · P/E 20, $344.27B cap vs $8.6M cap
Morgan Stanley (MS) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
MS does not have a complete income-statement cache yet.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
MS currently screens at market cap $344.27B and trailing P/E 19.8. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the MS and PMCB stock pages for the full models.
Not investment advice.